BEACOPP
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for BEACOPP | |
|
Articles | |
|---|---|
|
Most recent articles on BEACOPP | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on BEACOPP at Clinical Trials.gov Clinical Trials on BEACOPP at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on BEACOPP
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating BEACOPP Risk calculators and risk factors for BEACOPP
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for BEACOPP | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
BEACOPP is a chemotherapy regimen for treatment of Hodgkin's lymphoma in Stages > II. Patients typically receive treatment in cycles of 21 days with no drugs given on days 16-21. There also exists a more intensive regimen with cycles of 14 days. Usually a therapy consists of eight, sometimes six cycles. In some countries BEACOPP still is experimental, in others (eg. Germany and Austria) it is a standard therapy. The reason that the United States physicians still use ABVD (or Stanford V) is that they think that BEACOPP induces more secondary neoplasias as leukemias, etc. However, this (after 10 years of experience) is not the case. BEACOPP delivers approximately 10-15% more cures in advanced Hodgkins disease (IIB+risk factors or stages III and IV). BEACOPP is more expensive as it requires G-CSF support. However, it is well worth it because of the higher cure rates.
m² = body surface
i.v.=intravenous
BEACOPP basic:
| (C)yclophosphamide | 650 mg/m² | (i.v.) | day 1 |
| (A)driamycin | 25 mg/m² | i.v. | day 1 |
| (E)toposide | 100 mg/m² | i.v. | day 1-3 |
| Vincristin(=(O)ncovin) | 1,4 mg/m² (max 2 mg) | i.v. | day 8 |
| (B)leomycin | 10 mg/m² | i.v. | day 8 |
| (P)rocarbazine | 100 mg/m² | orally | day 1-7 |
| (P)rednisone | 40 mg/m² | orally | day 1-14 |
BEACOPP escalated:
| Cyclophosphamide | 1250 mg/m² KO/day | i.v. | day 1 |
| Adriamycin | 35 mg/m² | i.v. | day 1 |
| Etoposide | 200 mg/m² | i.v. | day 1-3 |
| Vincristine | 1,4 mg/m² (max 2 mg) | i.v. | day 8 |
| Bleomycin | 10 mg/m² | i.v. | day 8 |
| Procarbazine | 100 mg/m² | orally | day 1-7 |
| Prednisone | 40 mg/m² | orally | day 1-14 |
See also
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
